Apple Brings to Light that new Research Studies have begun for Epilepsy, Autism & Melanoma using ResearchKit
Last Saturday we posted a report titled "Boston Children's Hospital Rolled out their new Hep-C Tracker Program and iApp that Relies on ResearchKit Exclusively." One of the first institutions to be involved with ResearchKit was Boston Children's Hospital. Kenneth Mandl, MD, MPH, of the Boston Children's Hospital Informatics Program stated at the time that "Because of the ubiquity of iPhone and the elegant implementation of consent, survey and instrumented data collection, ResearchKit has enormous promise for leading the transformation of how we engage patients in research. Beyond the new Hep-C Tracker study that has begun at Boston's Children's Hospital, we learn today from Apple that several new ResearchKit studies have begun for autism, epilepsy and melanoma.
In a prepared statement found on Apple's press release, Jeff Williams, Apple's senior vice president of Operations stated that "We're honored to work with world-class medical institutions and provide them with tools to better understand diseases and ultimately help people lead healthier lives. In just six months, ResearchKit apps studying everything from asthma and diabetes to Parkinson's disease, are already providing insights to scientists around the world and more than 100,000 participants are choosing to contribute their data to advance science and medical research."
In July the participants were tallied at approximately 75,000 and so the reach of ResearchKit is expanding rapidly.
For more information on today's developments, see Apple's full press release here.
John Hopkins EpiWatch
Today, in sync with Apple's press release, John Hopkins released a video relating to their study that works with the iPhone and Apple Watch.